Drug profile · INN
norepinephrine bitartrate
NOREPINEPHRINE BITARTRATE
norepinephrine bitartrate (NOREPINEPHRINE BITARTRATE) is a adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — norepinephrine bitartrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
norepinephrine bitartrate (NOREPINEPHRINE BITARTRATE) is a adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor agonist
Primary target: Adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is norepinephrine bitartrate?
norepinephrine bitartrate (NOREPINEPHRINE BITARTRATE) is a adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for norepinephrine bitartrate?
NOREPINEPHRINE BITARTRATE is a marketed brand name for norepinephrine bitartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of norepinephrine bitartrate?
norepinephrine bitartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.